Diagnos Inc (ADK) - Total Assets

Latest as of September 2025: CA$1.17 Million CAD ≈ $847.95K USD

Based on the latest financial reports, Diagnos Inc (ADK) holds total assets worth CA$1.17 Million CAD (≈ $847.95K USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Diagnos Inc shareholders equity for net asset value and shareholders' equity analysis.

Diagnos Inc - Total Assets Trend (2002–2025)

This chart illustrates how Diagnos Inc's total assets have evolved over time, based on quarterly financial data.

Diagnos Inc - Asset Composition Analysis

Current Asset Composition (March 2025)

Diagnos Inc's total assets of CA$1.17 Million consist of 95.3% current assets and 4.7% non-current assets.

Asset Category Amount (CAD) % of Total Assets
Cash & Equivalents CA$0.00 2.4%
Accounts Receivable CA$10.41K 0.3%
Inventory CA$0.00 0.0%
Property, Plant & Equipment CA$0.00 0.0%
Intangible Assets CA$0.00 0.0%
Goodwill CA$0.00 0.0%

Asset Composition Trend (2002–2025)

This chart illustrates how Diagnos Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Diagnos Inc.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Diagnos Inc's current assets represent 95.3% of total assets in 2025, an increase from 21.6% in 2002.
  • Cash Position: Cash and equivalents constituted 2.4% of total assets in 2025, up from 2.3% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
  • Asset Diversification: The largest asset category is accounts receivable at 0.3% of total assets.

Diagnos Inc Competitors by Total Assets

Key competitors of Diagnos Inc based on total assets are shown below.

Company Country Total Assets
Longmaster Information Tech
SHE:300288
China CN¥1.33 Billion
Echoiq Ltd
AU:EIQ
Australia AU$17.99 Million
ARTRYA Ltd
AU:AYA
Australia AU$23.68 Million
Pharmx Technologies Ltd
AU:PHX
Australia AU$18.82 Million
Intelicare Holdings Ltd
AU:ICR
Australia AU$1.64 Million
Global Health Ltd
AU:GLH
Australia AU$2.84 Million
Newtopia Inc
V:NEWU
Canada CA$664.83K
Pro Medicus Ltd
AU:PME
Australia AU$533.91 Million

Diagnos Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.39 1.09 2.82
Quick Ratio 0.39 1.09 2.82
Cash Ratio 0.00 0.00 0.00
Working Capital CA$-1.45 Million CA$227.68K CA$1.06 Million

Diagnos Inc - Advanced Valuation Insights

This section examines the relationship between Diagnos Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 111.43
Latest Market Cap to Assets Ratio 4.66
Asset Growth Rate (YoY) 447.8%
Total Assets CA$3.64 Million
Market Capitalization $16.95 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Diagnos Inc's assets at a significant premium (4.66x), suggesting investors see substantial growth potential or unique competitive advantages.

Rapid Asset Growth: Diagnos Inc's assets grew by 447.8% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Diagnos Inc (2002–2025)

The table below shows the annual total assets of Diagnos Inc from 2002 to 2025.

Year Total Assets Change
2025-03-31 CA$3.64 Million
≈ $2.63 Million
+447.78%
2024-03-31 CA$663.79K
≈ $480.17K
-19.35%
2023-03-31 CA$823.03K
≈ $595.37K
-46.61%
2022-03-31 CA$1.54 Million
≈ $1.12 Million
-20.96%
2021-03-31 CA$1.95 Million
≈ $1.41 Million
-19.87%
2020-03-31 CA$2.43 Million
≈ $1.76 Million
+101.63%
2019-03-31 CA$1.21 Million
≈ $873.23K
-20.80%
2018-03-31 CA$1.52 Million
≈ $1.10 Million
+16.42%
2017-03-31 CA$1.31 Million
≈ $947.09K
+3.04%
2016-03-31 CA$1.27 Million
≈ $919.15K
+8.39%
2015-03-31 CA$1.17 Million
≈ $848.00K
-25.71%
2014-03-31 CA$1.58 Million
≈ $1.14 Million
-28.98%
2013-03-31 CA$2.22 Million
≈ $1.61 Million
-16.21%
2012-03-31 CA$2.65 Million
≈ $1.92 Million
+75.17%
2011-03-31 CA$1.51 Million
≈ $1.10 Million
-33.42%
2010-03-31 CA$2.27 Million
≈ $1.64 Million
-14.61%
2009-03-31 CA$2.66 Million
≈ $1.93 Million
-45.34%
2008-03-31 CA$4.87 Million
≈ $3.52 Million
+204.16%
2007-03-31 CA$1.60 Million
≈ $1.16 Million
+66.10%
2006-03-31 CA$964.27K
≈ $697.54K
+155.93%
2005-03-31 CA$376.77K
≈ $272.55K
-47.08%
2004-03-31 CA$711.90K
≈ $514.98K
+183.79%
2003-03-31 CA$250.86K
≈ $181.47K
-27.68%
2002-03-31 CA$346.87K
≈ $250.92K
--

About Diagnos Inc

V:ADK Canada Health Information Services
Market Cap
$16.95 Million
CA$23.43 Million CAD
Market Cap Rank
#25530 Global
#1024 in Canada
Share Price
CA$0.23
Change (1 day)
-2.13%
52-Week Range
CA$0.19 - CA$0.38
All Time High
CA$1.95
About

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and patho… Read more